Core Viewpoint - China Biotechnology Services (08037) has successfully completed the issuance of convertible bonds totaling $35 million, with all conditions of the subscription agreement met as of February 20, 2026 [1] Group 1: Convertible Bonds Issuance - The company issued convertible bonds with a principal amount of $35 million, completing the issuance as per the terms of the subscription agreement [1] - Prior to this issuance, there was an outstanding principal amount of $6 million from the 2024 convertible bonds, which can be converted into a total of 39.25 million shares at a conversion price of HKD 1.20 per share [1] - Following the completion of the new convertible bond issuance, the conversion price for the 2024 convertible bonds has been adjusted from HKD 1.20 to HKD 1.11 per share, effective from February 20, 2026 [1] Group 2: Share Issuance and Terms - The maximum number of shares to be issued upon full conversion of the 2024 convertible bonds is 42.432 million shares, effective from the completion date of the new convertible bond issuance [1] - All other terms of the 2024 convertible bonds remain unchanged despite the adjustment in the conversion price [1]

Core Viewpoint - China Water Industry Group (01129) has announced a conditional agreement to issue convertible bonds totaling HKD 278 million (approximately RMB 250 million) to several subscribers, with the proceeds intended for debt repayment [1] Group 1: Convertible Bonds Issuance - The company has entered into a subscription agreement with several parties, including Huaniu International Limited and Digital Advisors Limited, for the issuance of convertible bonds [1] - The initial conversion price is set at HKD 0.308 per share, which could lead to the issuance of up to 903 million shares upon full conversion, representing approximately 142.90% of the current issued share capital [1] - The estimated net proceeds from the bond issuance, after deducting related expenses, will be approximately HKD 278 million, which will be used to repay IFC debt and other liabilities [1] Group 2: Share Capital Impact - Upon full conversion of the bonds, the expanded issued share capital will increase by approximately 58.83%, assuming no changes in the company's issued capital from the announcement date until conversion [1] - The net price per share for the convertible bonds is approximately HKD 0.307, calculated by dividing the total net proceeds by the maximum number of shares to be issued [1]

Core Viewpoint - Yongtai Bio-B (06978) has announced a conditional agreement to issue new convertible bonds worth RMB 270 million and notes worth RMB 30 million, aimed at repaying existing convertible bonds due on February 20, 2026 [1] Group 1: Convertible Bonds and Notes - The new convertible bonds will have an initial conversion price of HKD 2.92 per share, equivalent to RMB 2.62 [1] - Upon full exercise of the conversion rights attached to the new convertible bonds, a maximum of 103 million shares will be issued, representing approximately 16.66% of the existing issued shares and about 14.28% of the enlarged issued shares after the conversion [1] Group 2: Use of Proceeds - The proceeds from the subscription will be exclusively used for the full and final repayment of the outstanding principal amount of the 2023 convertible bonds [1] Group 3: Conditions and Guarantees - The new convertible bonds and notes will be secured by collateral as outlined in the relevant documentation [1] - Upon receipt of the new convertible bonds and notes, and after the company has paid the accrued unpaid interest on the 2023 convertible bonds, the investors will sign a repayment deed confirming the full and final repayment of the 2023 convertible bonds [1]

Core Viewpoint - Yongtai Bio-B (06978) has announced a conditional agreement to issue new convertible bonds worth RMB 270 million and notes worth RMB 30 million, aimed at repaying existing convertible bonds due on February 20, 2026 [1] Group 1: Convertible Bonds and Notes - The new convertible bonds will have an initial conversion price of HKD 2.92 per share, equivalent to RMB 2.62 [1] - Upon full exercise of the conversion rights attached to the new convertible bonds, a maximum of 103 million shares will be issued, representing approximately 16.66% of the existing issued shares and about 14.28% of the enlarged issued shares after the conversion [1] Group 2: Use of Proceeds - The proceeds from the subscription will be exclusively used for the full and final repayment of the 2023 convertible bonds [1] - The issuance of the new convertible bonds and notes will be secured by collateral as per the relevant documentation [1] Group 3: Conditions and Agreements - The investors are required to sign a repayment deed in favor of the company, confirming the full and final repayment of the 2023 convertible bonds upon receipt of the new convertible bonds and notes [1]

Core Viewpoint - Zoomlion Heavy Industry Science and Technology Co., Ltd. has successfully completed the issuance of USD-denominated convertible bonds totaling RMB 6 billion (approximately HKD 6.745 billion) as of February 5, 2026, with all preconditions of the subscription agreement met [1] Group 1 - The net proceeds from the issuance of the convertible bonds, after deducting expenses, commissions, and other issuance costs, amount to approximately RMB 5.942 billion (around HKD 6.680 billion) [1] - The company plans to utilize the net proceeds in accordance with the disclosed methods in the announcement [1] - Approval for the listing and trading of the convertible bonds on the Hong Kong Stock Exchange is expected to take effect on February 6, 2026 [1] Group 2 - The company has also received approval for the listing of conversion shares on the Hong Kong Stock Exchange [1]

Group 1 - Tianqi Lithium Industries (002466) experienced a significant drop of over 9% upon resuming trading, with a current price of 44.98 HKD and a trading volume of 74.6883 million HKD [1] - The company announced a plan to place 65.05 million new H-shares and issue zero-coupon convertible bonds totaling 2.6 billion RMB, with expected total proceeds of approximately 5.8591 billion HKD, net proceeds around 5.8306 billion HKD [1] - The funds raised will support the company's strategic development in the lithium sector, including capital expenditures for project development and optimization, acquisition of quality lithium mining assets, and general corporate purposes [1] Group 2 - The company has entered into a revised placement agreement for the new H-shares, with a placement price of 45.05 HKD per share, representing a discount of about 9% compared to the last closing price of 49.5 HKD on February 3, 2026 [1] - The total expected proceeds from the placement of shares is approximately 2.9305 billion HKD, with net proceeds estimated at around 2.924 billion HKD [1] - Additionally, the company will issue zero-coupon convertible bonds with a principal amount of 2.6 billion RMB, with an initial conversion price of 51.85 HKD per H-share, representing a premium of about 4.7% over the last closing price [2] - The total expected proceeds from the bond issuance is approximately 2.9286 billion HKD, with net proceeds estimated at around 2.9066 billion HKD [2]

Group 1 - The company plans to issue RMB 60 billion convertible bonds maturing in 2031 based on special authorization [1] - The bonds will be issued at a fixed exchange rate, approximately equivalent to HKD 67.452 billion [1] - The underwriters have agreed to subscribe to the bonds under specific terms outlined in the subscription agreement [1] Group 2 - The convertible bonds can be converted into H-shares at an initial conversion price of HKD 10.02 per share [2] - If fully converted, the bonds will result in approximately 673,188,000 H-shares, representing about 43.36% of the company's issued H-shares as of the announcement date [2] - After full conversion, the newly issued shares will account for 30.25% of the enlarged total issued H-shares [2]

Core Viewpoint - Zhonglian Heavy Industry (01157.HK) has entered into a subscription agreement to issue convertible bonds worth RMB 6 billion (approximately HKD 6.745 billion) with underwriters including Huatai International, HSBC, and Morgan Stanley [1] Group 1: Convertible Bonds Issuance - The company has agreed to issue convertible bonds to the underwriters, who will subscribe to the bonds under specific terms outlined in the subscription agreement [1] - The final terms of the convertible bonds, including principal amount and initial conversion price, were determined after the underwriters conducted book building on January 28, 2026 [1] Group 2: Conversion Details - If the convertible bonds are fully converted at the initial conversion price of HKD 10.02 per share, they will convert into approximately 673 million H-shares, representing about 43.36% of the company's total issued H-shares and 7.78% of the total issued share capital as of the announcement date [1] - The initial conversion price of HKD 10.02 per share is at a premium of approximately 18.58% compared to the last trading price of HKD 8.45 per share on the Hong Kong Stock Exchange [1] Group 3: Fundraising Expectations - The net proceeds from the issuance of the convertible bonds are expected to be approximately RMB 59.42 billion (around HKD 66.80 billion) [1]

Core Viewpoint - China Ruyi (00136.HK) has entered into a subscription agreement with Deutsche Bank Hong Kong Branch to issue HKD 2.574 billion zero-coupon convertible bonds due in 2027, which will convert into approximately 990 million shares, representing about 5.89% of the existing issued share capital as of the announcement date [1]. Group 1 - The total principal amount of the bonds to be issued is HKD 2.574 billion [1]. - The net proceeds from the bond issuance are expected to be approximately HKD 2.548 billion after deducting fees, commissions, and other related expenses [1]. - The initial conversion price is set at HKD 2.6 per share [1]. Group 2 - The intended use of the net proceeds includes: - Approximately 23.27% for repaying group debt [1]. - Approximately 14.36% for part of the cost to acquire a 30% stake in Beijing Yonghang Technology Co., Ltd. [1]. - Approximately 20.02% for strategic investments and acquisitions to expand the group's business [1]. - Approximately 15.31% for operational needs of the group's gaming business [1]. - Approximately 27.04% for content production on the streaming platform [1].

Core Viewpoint - China Ruyi (00136) has entered into a subscription agreement with the lead underwriter to issue bonds totaling HKD 2.574 billion, which can be converted into approximately 990 million shares, representing about 5.89% of the company's existing issued share capital [1] Group 1: Bond Issuance Details - The total principal amount of the bonds to be issued is HKD 25.74 billion, subject to the terms and conditions of the subscription agreement [1] - The estimated net proceeds from the bond issuance, after deducting expenses, commissions, and other related costs, is approximately HKD 25.48 billion, equating to a net issue price of about HKD 2.574 per share [1] Group 2: Use of Proceeds - Approximately 23.27% of the net proceeds will be used to repay group debt [1] - About 14.36% will be allocated for part of the cost to acquire a 30% stake in Beijing Yonghang Technology Co., Ltd [1] - Approximately 20.02% will be used for strategic investments and acquisitions to expand the group's business [1] - Around 15.31% will be utilized for operational needs of the group's gaming business [1] - About 27.04% will be directed towards the production of series for the streaming platform [1]